Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-31

FDA Approved: DAPSONE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved the Original Application for Dapsone (DAPSONE) by Amneal Pharmaceuticals NY LLC, authorizing a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DAPSONE (dapsone)

Snippet

ORIG AP for DAPSONE (DASPONE)